Clinical Trial Update: Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU) [Phase 1, Phase 2]

View source ↗

Summary

Pharmacokinetic study of bilastine in children aged 2 to under 12 with allergic rhinoconjunctivitis or chronic urticaria (Phase 1/2). The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinoconjunctivitis
• Urticaria

Drugs mentioned

• Bilastine (bilastine)

Snippet

Sponsor: Faes Farma, S.A. | Conditions: Allergic Rhinoconjunctivitis, Chronic Urticaria | Phase 1, Phase 2 | Status: COMPLETED